[
  {
    "start": "0",
    "end": "140000"
  },
  {
    "text": "Today, we're talking about immunology as you may recall.    Let's roll.  Yes, let's roll.    ",
    "start": "0",
    "end": "12000"
  },
  {
    "text": "And by the way,  admire your little finger,    because most of the planet isn't as gifted as you are.   ",
    "start": "12000",
    "end": "21000"
  },
  {
    "text": "Not everyone was guaranteed so many brains as you and I,    seriously, have been fortunate enough to have been granted.   ",
    "start": "21000",
    "end": "31000"
  },
  {
    "text": "Let me just finish up what we were talking about last time,     which was the cell cycle.   ",
    "start": "31000",
    "end": "44000"
  },
  {
    "text": "You may recall that we talked about oncogenes.  We talked about Ras and   the Ras oncoprotein,  which sends out mytogenic signals.   ",
    "start": "44000",
    "end": "52000"
  },
  {
    "text": "And, what it does, just to summarize what we were talking about   is it pushes cells from the beginning of the G1 phase of the  ",
    "start": "52000",
    "end": "60000"
  },
  {
    "text": "cell cycle up to a decision point in the life of the cell.    It's called the restriction point.  And here, just by way of review,   ",
    "start": "60000",
    "end": "69000"
  },
  {
    "text": "the cell has to decide whether or not it's going to commit itself,    essentially irreversibly, to go through the rest of the cell cycle,   ",
    "start": "69000",
    "end": "77000"
  },
  {
    "text": "or whether it'll stay in G1, and may even retreat from the cell cycle   into G0.  And Ras pushes this decision forward.   ",
    "start": "77000",
    "end": "86000"
  },
  {
    "text": "The retinoblastoma protein,  which we talked about the last time,    stands as the guardian of the gate right here, the RB protein.   ",
    "start": "86000",
    "end": "95000"
  },
  {
    "text": "And, the retinoblastoma protein holds this gate shut unless and   until certain preconditions have been satisfied,   ",
    "start": "95000",
    "end": "101000"
  },
  {
    "text": "on which occasion the retinoblastoma protein opens up the restriction   point gate, and allows the cell to go through the rest of the cell  ",
    "start": "101000",
    "end": "108000"
  },
  {
    "text": "cycle.  And now,  interviewed from this perspective,    we can begin to understand how hyperactivity of Ras,   ",
    "start": "108000",
    "end": "115000"
  },
  {
    "text": "and how the inactivation of this RB,  this retinoblastoma, tumor   suppressor protein have such disruptive destabilizing effects on  ",
    "start": "115000",
    "end": "122000"
  },
  {
    "text": "the proliferative controls of the cell.    Keep in mind, this is a negative actor on cell proliferation.   ",
    "start": "122000",
    "end": "130000"
  },
  {
    "text": "It's a tumor suppressor gene which must be inactivated in many cancers.    This is a proto-oncogene, or an oncogene, which must become  ",
    "start": "130000",
    "end": "138000"
  },
  {
    "text": "hyperactivated.  Now, I want to move from that into   the topic of today,  and that's the whole issue of  ",
    "start": "138000",
    "end": "146000"
  },
  {
    "start": "140000",
    "end": "290000"
  },
  {
    "text": "immunity.  And, much of our immunity comes from   understanding the way we deal with what viral infections.   ",
    "start": "146000",
    "end": "155000"
  },
  {
    "text": "The fact is, just to cite one arbitrary viral infection,    relatively few people die from viral infections these days because we can  ",
    "start": "155000",
    "end": "164000"
  },
  {
    "text": "become immunized against them.  The first immunizations already   began in the late 18th century,  believe it or not, when a physician  ",
    "start": "164000",
    "end": "172000"
  },
  {
    "text": "in England called Edward Jenner first noticed that women who had   worked as milkmaids milking cows,  and who got a disease called cowpox  ",
    "start": "172000",
    "end": "181000"
  },
  {
    "text": "from milking the cows seemed to be immune to the disease of smallpox   which was by that time realized to be spreading in epidemic,   ",
    "start": "181000",
    "end": "190000"
  },
  {
    "text": "so a highly infectious agent,  and one which actually killed quite   a few people.  And Jenner intuited correctly,   ",
    "start": "190000",
    "end": "199000"
  },
  {
    "text": "in retrospect, that the experience of these milkmaids and their   exposure to cowpox exposure somehow protected them,   ",
    "start": "199000",
    "end": "209000"
  },
  {
    "text": "gave them indeed lifelong protection from subsequent smallpox infection.   ",
    "start": "209000",
    "end": "215000"
  },
  {
    "text": "Subsequently to that,  the sores from the cowpox infection   were scraped, and the exidate,  the fluid, was scratched into wounds  ",
    "start": "215000",
    "end": "224000"
  },
  {
    "text": "of people in order to immunize them.  And so, immunization them.  And so,    immunization already began in the 1790's, taking a sore from the skin  ",
    "start": "224000",
    "end": "234000"
  },
  {
    "text": "of a cowpox infected patient,  injecting that into the skin of   somebody who required immunization,  and as a consequence, hoping that  ",
    "start": "234000",
    "end": "244000"
  },
  {
    "text": "this would confer in them lifelong protection.    In some cases,  actually the individuals who were  ",
    "start": "244000",
    "end": "253000"
  },
  {
    "text": "infected in that way actually came down with smallpox or some virulent   form of this cowpox,  but in most other cases these  ",
    "start": "253000",
    "end": "261000"
  },
  {
    "text": "individuals actually acquired a lifelong immunity.    In fact, the very word vaccine,  which was used already at the time,   ",
    "start": "261000",
    "end": "269000"
  },
  {
    "text": "comes from the Latin word vaccinus which means a cow.    And, in the north side of Cambridge Common there's the Benjamin  ",
    "start": "269000",
    "end": "277000"
  },
  {
    "text": "Waterhouse which is still there.  He was the first physician to   introduce smallpox vaccination into this country already in the end of  ",
    "start": "277000",
    "end": "287000"
  },
  {
    "text": "the 18th century.  If we fast forward to a situation   like poliovirus,  we have situations in this country  ",
    "start": "287000",
    "end": "297000"
  },
  {
    "start": "290000",
    "end": "803000"
  },
  {
    "text": "where in the 1930's-1940's,  there were epidemics of poliovirus.    If one began to examine who was susceptible and who wasn't,   ",
    "start": "297000",
    "end": "306000"
  },
  {
    "text": "it was clear that children who were,  for example, born and raised in   middle and upper-middle class houses were very susceptible for much of  ",
    "start": "306000",
    "end": "314000"
  },
  {
    "text": "their lives.  For example,  in southern California there were   dramatic examples,  whereas children who grew up across  ",
    "start": "314000",
    "end": "322000"
  },
  {
    "text": "the border in,  let's say, Tijuana,    Mexico, rarely came down with paralytic polio.   ",
    "start": "322000",
    "end": "330000"
  },
  {
    "text": "Poliovirus, as one soon learned,  was a virus which infects not only   the gastrointestinal tract,  and creates a form of mild diarrhea,   ",
    "start": "330000",
    "end": "338000"
  },
  {
    "text": "but it may be one out of 100 persons the virus escapes from the GI tract,    from the gastrointestinal tract,  invades into the central nervous  ",
    "start": "338000",
    "end": "347000"
  },
  {
    "text": "system, and actually creates debilitating paralysis,    most of which is not healed.  And some people have lifelong  ",
    "start": "347000",
    "end": "356000"
  },
  {
    "text": "paralysis.  Other individuals whose paralytic   paralysis goes away,  actually when they grow older,   ",
    "start": "356000",
    "end": "365000"
  },
  {
    "text": "30, 40, 50 years later, they begin once again to experience the   paralytic symptoms that arose as a consequence of their childhood  ",
    "start": "365000",
    "end": "373000"
  },
  {
    "text": "infection.  And at this time,  one began to try to figure out why   children living in Tijuana,  Mexico rarely came down with  ",
    "start": "373000",
    "end": "381000"
  },
  {
    "text": "poliovirus infections,  whereas those who grew up up north   like, say, in southern California did indeed do so.   ",
    "start": "381000",
    "end": "390000"
  },
  {
    "text": "And one came to the conclusion that the children growing up in Tijuana,    Mexico were frequently exposed very early in their life to contaminated  ",
    "start": "390000",
    "end": "398000"
  },
  {
    "text": "water, sewage contaminated water,  and they as a consequence acquired a   lifelong immunity without getting sick, whereas children who grew up  ",
    "start": "398000",
    "end": "406000"
  },
  {
    "text": "in rather sterile conditions further north never had any exposure to the   virus.  And when it hit them as young adults or as teenagers,   ",
    "start": "406000",
    "end": "415000"
  },
  {
    "text": "it created devastating effects.  And this indicates, once again,    that somehow one's exposure to an infectious agent,   ",
    "start": "415000",
    "end": "423000"
  },
  {
    "text": "historical exposure has a dramatic effect on one's susceptibility   to a virus.  And in the case of poliovirus,   ",
    "start": "423000",
    "end": "432000"
  },
  {
    "text": "we're dealing here with an agent which is much simpler than the   retroviruses we talked about last time like RSV.   ",
    "start": "432000",
    "end": "440000"
  },
  {
    "text": "Poliovirus also has a single stranded RNA genome,    and that's encapsidated in a proteinaceous coat,   ",
    "start": "440000",
    "end": "449000"
  },
  {
    "text": "which is made up only of viral proteins, so it's very simple single   stranded RNA proteinaceous coat.  The single stranded RNA is actually  ",
    "start": "449000",
    "end": "457000"
  },
  {
    "text": "polyadenylated at the three prime end.  So, it can serve as a   messenger RNA.  It's of the same polarity that has  ",
    "start": "457000",
    "end": "464000"
  },
  {
    "text": "a plus polarity,  which means that it can be   translated immediately.  I'm distinguishing that from the  ",
    "start": "464000",
    "end": "470000"
  },
  {
    "text": "other flavor of single stranded RNA which could be of the complementary   strand, which could exist because one could make double stranded RNA  ",
    "start": "470000",
    "end": "477000"
  },
  {
    "text": "which obviously cannot be translated.    So, this can serve as a messenger RNA, and just as an aside,   ",
    "start": "477000",
    "end": "485000"
  },
  {
    "text": "the way that poliovirus replicates is totally different from that of   retroviruses.  What happens is that poliovirus makes its own polymerase.   ",
    "start": "485000",
    "end": "494000"
  },
  {
    "text": "You go from single stranded RNA to double stranded RNA,    i.e. the complementary copy is made,  and that in turn is used as a  ",
    "start": "494000",
    "end": "504000"
  },
  {
    "text": "template for making more single stranded RNA, progeny RNA.    And note here that there's no DNA at all involved.  In fact,   ",
    "start": "504000",
    "end": "513000"
  },
  {
    "text": "poliovirus can grow inside a cell that has been deprived of its   nucleus.  Moreover,  if one stops nuclear DNA dependent  ",
    "start": "513000",
    "end": "521000"
  },
  {
    "text": "transcription,  that has no effect on this.    But you'll notice correctly that these kind of steps here involved  ",
    "start": "521000",
    "end": "529000"
  },
  {
    "text": "RNA dependent RNA polymerases.  And in the normal physiology of a   cell, that such a polymerase,  such an enzyme never operates.   ",
    "start": "529000",
    "end": "538000"
  },
  {
    "text": "And therefore, poliovirus must make among its other proteins an RNA   dependent RNA polymerase that can mediate these steps: making a  ",
    "start": "538000",
    "end": "546000"
  },
  {
    "text": "complementary copy of this strand,  to get the complementary strand, and   then making progeny plus strand RNAs.   ",
    "start": "546000",
    "end": "555000"
  },
  {
    "text": "Again, it has a very simple capsid of several viral proteins which wrap   it up.  Now, if one wants to assess the potency of poliovirus RNA,   ",
    "start": "555000",
    "end": "564000"
  },
  {
    "text": "one can grow it in a Petri dish.  One way of figuring out how much   poliovirus RNA is in a solution is to make a monolayer of cells like  ",
    "start": "564000",
    "end": "573000"
  },
  {
    "text": "this, and then take various dilutions of a virus stalk.    And when one talks about a virus stalk, one talks about a solution of  ",
    "start": "573000",
    "end": "581000"
  },
  {
    "text": "virus particles.  One can't really see them.    And even if one could see them under the electron microscope,   ",
    "start": "581000",
    "end": "587000"
  },
  {
    "text": "one wouldn't really know what fraction of the ones you were seeing   were actually biologically competent.  But most interestingly,   ",
    "start": "587000",
    "end": "594000"
  },
  {
    "text": "you can take a solution of poliovirus particles,    place it on a monolayer of cells here, which can be infected  ",
    "start": "594000",
    "end": "601000"
  },
  {
    "text": "by poliovirus.  In contrast to what I told you last   time about RSV,  where an infected cell can tolerate  ",
    "start": "601000",
    "end": "609000"
  },
  {
    "text": "the continued presence of a viral infection without dying,    poliovirus is a highly cytopathic virus, and by that I mean it  ",
    "start": "609000",
    "end": "617000"
  },
  {
    "text": "replicates inside cells and it kills them during the course of   replicating inside these cells.  So, here what one has is just a  ",
    "start": "617000",
    "end": "625000"
  },
  {
    "text": "poliovirus will infect a cell here,  and then it will begin to spread   from that cell to neighboring cells in the surrounds.   ",
    "start": "625000",
    "end": "634000"
  },
  {
    "text": "And in so doing it will create,  it will erode a hole right here in   the monolayer whose presence,  a so-called plaque, signifies the  ",
    "start": "634000",
    "end": "641000"
  },
  {
    "text": "fact that there was an initially infecting virus particle there that   spreads centrifugally,  that spread outward, from the  ",
    "start": "641000",
    "end": "649000"
  },
  {
    "text": "initially infected cell.  In detail, if you want to do this   experiment really nicely,  what you do after you infect the  ",
    "start": "649000",
    "end": "657000"
  },
  {
    "text": "initial monolayer of cells,  which I show here in section,    is you put on a layer of agarose,  or something, above the infected  ",
    "start": "657000",
    "end": "665000"
  },
  {
    "text": "monolayer, and that ensures that if there's any viral spread,    it will be from cell to cell spread in a certain neighborhood rather  ",
    "start": "665000",
    "end": "673000"
  },
  {
    "text": "than virus particles getting into solution and swimming around all   over the plate and affecting cells helter-skelter.   ",
    "start": "673000",
    "end": "681000"
  },
  {
    "text": "So here, we might want to infect an initial cell right here in the   monolayer, and now this agarose will confine the subsequent spread of  ",
    "start": "681000",
    "end": "688000"
  },
  {
    "text": "progeny virus to adjacent cells in the area, again eroding,    ultimately, a hole here which we call a plaque.   ",
    "start": "688000",
    "end": "696000"
  },
  {
    "text": "And if we count the number of plaques, that will tell us how many   biologically active virus particles there were in the initial solution  ",
    "start": "696000",
    "end": "705000"
  },
  {
    "text": "that was previously applied to that monolayer culture of the susceptible   cells.  One could use such monolayer cultures, in fact, to propagate  ",
    "start": "705000",
    "end": "714000"
  },
  {
    "text": "poliovirus.  And one can take the poliovirus   coming out of those monolayer cultures, and actually use them to  ",
    "start": "714000",
    "end": "722000"
  },
  {
    "text": "inject into human beings in order to vaccinate them to confer on them   immunity.  But if you do that with wild type poliovirus,   ",
    "start": "722000",
    "end": "729000"
  },
  {
    "text": "then what will happen is that you may inadvertently give that person   whom you're attempting to immunize a nasty poliovirus infection which  ",
    "start": "729000",
    "end": "737000"
  },
  {
    "text": "could paralyze them,  might even kill them.    When I was growing up,  poliovirus infections were much  ",
    "start": "737000",
    "end": "744000"
  },
  {
    "text": "dreaded because we knew of people who were being kept alive in iron   lungs that breathe for them because their autonomic nervous system had  ",
    "start": "744000",
    "end": "752000"
  },
  {
    "text": "been destroyed by a poliovirus infection.    So, what happens is therefore if one wishes to immunize somebody,   ",
    "start": "752000",
    "end": "760000"
  },
  {
    "text": "if one wishes to vaccinate them against poliovirus,    one needs to inject them with an attenuated virus,   ",
    "start": "760000",
    "end": "769000"
  },
  {
    "text": "that is, a virus whose ability to create disease,    whose pathogenic abilities,  pathogenic, remember, refers to the  ",
    "start": "769000",
    "end": "778000"
  },
  {
    "text": "ability to create disease.  You want to use an attenuated virus,    which might be able to go into the body.  It might be able to evoke  ",
    "start": "778000",
    "end": "787000"
  },
  {
    "text": "immunity, but it will not create a major disease response.    And this was dealt with in two different ways.   ",
    "start": "787000",
    "end": "796000"
  },
  {
    "text": "Jonas Salk, one of the pioneers of creating a poliovirus vaccine took   the poliovirus particles that have been produced by culturing them on  ",
    "start": "796000",
    "end": "805000"
  },
  {
    "text": "monolayers of monkey kidney cells,  and he treated the poliovirus   briefly with a little bit of formaldehyde.   ",
    "start": "805000",
    "end": "815000"
  },
  {
    "text": "And formaldehyde,  as you may know, reacts with the   amine groups of the ribonucleosides,  of the purines and pyrimidines, and  ",
    "start": "815000",
    "end": "823000"
  },
  {
    "text": "therefore kills the virus.  And that kill virus, having been   treated briefly with the formaldehyde, the virus particle is  ",
    "start": "823000",
    "end": "831000"
  },
  {
    "text": "still essentially intact,  was then injected into individuals.     Alternatively,   ",
    "start": "831000",
    "end": "840000"
  },
  {
    "text": "his deadly rival,  because they two hated each other's   guts, Sabin decided on another strategy for making a vaccine stalk.   ",
    "start": "840000",
    "end": "848000"
  },
  {
    "text": "And that is, he took poliovirus which had been passage from one cell   culture to the next over extended periods of time,   ",
    "start": "848000",
    "end": "857000"
  },
  {
    "text": "over several years.  So, it had been passage in vitro.    When we say in vitro, in this context we mean poliovirus had been  ",
    "start": "857000",
    "end": "866000"
  },
  {
    "text": "taken from one plate,  put into another plate of cells,    taken to another plate of cells.  In vitro here implies in culture  ",
    "start": "866000",
    "end": "875000"
  },
  {
    "text": "rather than the other alternative.  In vivo means that the virus is   being passaged in a living organism.  And as it turns out, when you  ",
    "start": "875000",
    "end": "883000"
  },
  {
    "start": "878000",
    "end": "1068000"
  },
  {
    "text": "passage poliovirus in vitro from passing it just from one culture of   cells to the next,  infecting one after another in a  ",
    "start": "883000",
    "end": "892000"
  },
  {
    "text": "serial or sequential fashion,  then the virus is selected for its   ability to proliferate in the cultured cells in vitro.   ",
    "start": "892000",
    "end": "901000"
  },
  {
    "text": "But it gradually loses its ability to create disease in vivo in that   there is no Darwinian selection to favor its disease causing ability.   ",
    "start": "901000",
    "end": "910000"
  },
  {
    "text": "And consequently, virus that Saben used wasn't inactivated with   formaldehyde.  It was a simply attenuated because of extensive in  ",
    "start": "910000",
    "end": "919000"
  },
  {
    "text": "vitro propagation.  And when he injected that into   young people, very rarely did they ever come down with poliovirus  ",
    "start": "919000",
    "end": "928000"
  },
  {
    "text": "infection, and the virus was able to replicate to some extent in their   bodies without causing disease,  and to create lifelong immunity.   ",
    "start": "928000",
    "end": "937000"
  },
  {
    "text": "I.e. such an individual was protected from subsequent poliovirus   infection ever again.  And, as it turned out,   ",
    "start": "937000",
    "end": "946000"
  },
  {
    "text": "this was a very nice way of protecting because it also turned   out the monkey kidney cells that were used to propagate the virus  ",
    "start": "946000",
    "end": "955000"
  },
  {
    "text": "also contained certain monkey viruses.  For example,    it came out after years that there was a DNA tumor virus.   ",
    "start": "955000",
    "end": "964000"
  },
  {
    "text": "We've been talking about RNA tumor viruses until now,    but there's a DNA tumor virus called SV40, which is a very potent tumor  ",
    "start": "964000",
    "end": "971000"
  },
  {
    "text": "virus in hamsters,  and mice, and rats.    And it turns out that SV40 lingered.  It lurked in monkey kidney cell  ",
    "start": "971000",
    "end": "978000"
  },
  {
    "text": "cultures.  And,  nobody knew about it.    Whenever you put poliovirus into many of these cultures,   ",
    "start": "978000",
    "end": "986000"
  },
  {
    "text": "not only did poliovirus replicate,  but all of a sudden so did SV40.    And therefore,  many of the stalks of poliovirus  ",
    "start": "986000",
    "end": "994000"
  },
  {
    "text": "that were used to inject people like myself, I lived around the corner in   Pittsburgh from Jonas Salk,  and the children in the Pittsburgh  ",
    "start": "994000",
    "end": "1002000"
  },
  {
    "text": "public schools were his first guinea pigs.  Many of us were exposed to   poliovirus stalk which actually had more SV40 particles in it than  ",
    "start": "1002000",
    "end": "1010000"
  },
  {
    "text": "poliovirus particles because of this inadvertent contamination.    There probably were between 30 and 40 million people who were immunized  ",
    "start": "1010000",
    "end": "1018000"
  },
  {
    "text": "with poliovirus and inadvertently with SV40 virus.    And one is that epidemiology in the subsequent years to figure out  ",
    "start": "1018000",
    "end": "1027000"
  },
  {
    "text": "whether that had led to any increased rate of cancer because it   could well have.  There could have been an epidemic  ",
    "start": "1027000",
    "end": "1035000"
  },
  {
    "text": "of cancer in this country,  millions of people affected because   of this unknown,  and at the time almost unknowable  ",
    "start": "1035000",
    "end": "1043000"
  },
  {
    "text": "contaminating virus.  As it turns out, people who were   infected with SV40 inadvertently have no higher rates of cancer than  ",
    "start": "1043000",
    "end": "1051000"
  },
  {
    "text": "anybody else even though this virus is a very potently tumorogenic virus   like RSV, but doing so in this case in rodent cells and ostensibly  ",
    "start": "1051000",
    "end": "1059000"
  },
  {
    "text": "not in humans.  So, public health measures can   sometimes have unforeseen side effects or consequences that nobody  ",
    "start": "1059000",
    "end": "1067000"
  },
  {
    "text": "anticipates ahead of time.  Now, getting back to the whole   strategy of poliovirus infection,  this raises the issue of what it was  ",
    "start": "1067000",
    "end": "1076000"
  },
  {
    "start": "1068000",
    "end": "1171000"
  },
  {
    "text": "in the poliovirus that was able to evoke the subsequent lifelong   immunity.  And in telling you that,  I mentioned the following.   ",
    "start": "1076000",
    "end": "1085000"
  },
  {
    "text": "You can make antiserum or you can make serum from an individual who's   been immunized with poliovirus.  And, recollect, we mentioned this  ",
    "start": "1085000",
    "end": "1093000"
  },
  {
    "text": "before, the way to make serum is to allow blood to clot.    The red cells and the platelets aggregate in the bottom,   ",
    "start": "1093000",
    "end": "1101000"
  },
  {
    "text": "and what remains on top is simply serum.  You can spin out all the   residual cells and so all you get is sort of a straw colored fluid.   ",
    "start": "1101000",
    "end": "1110000"
  },
  {
    "text": "And that serum from an individual who's been immunized with poliovirus   stalk can actually be used to,  you can add it to the poliovirus  ",
    "start": "1110000",
    "end": "1118000"
  },
  {
    "text": "stalk prior to adding these virus particles to the Petri dish.    So, here's the Petri dish as before,  and what you find is that if you add  ",
    "start": "1118000",
    "end": "1126000"
  },
  {
    "text": "serum from an individual who's been immunized to a solution of   poliovirus particles,  and then you take that mixture and  ",
    "start": "1126000",
    "end": "1134000"
  },
  {
    "text": "put them on the plate,  you no longer get any of these   plaques that I referred to before.   ",
    "start": "1134000",
    "end": "1143000"
  },
  {
    "text": "And that indicates that within the serum, there is some kind of factor   which is neutralizing the infectivity of the polio virus  ",
    "start": "1143000",
    "end": "1152000"
  },
  {
    "text": "particles, i.e.  the poliovirus particles are in some   way prevented from creating an infection, and their plaque forming  ",
    "start": "1152000",
    "end": "1161000"
  },
  {
    "text": "ability, their ability corrode these holes in the monolayers of   subsequently infected cultures is now compromised.   ",
    "start": "1161000",
    "end": "1171000"
  },
  {
    "start": "1171000",
    "end": "1340000"
  },
  {
    "text": "And such activity suggests that such an individual has actually antiserum,    i.e. some kind of reactivity which prevents the poliovirus particle  ",
    "start": "1171000",
    "end": "1179000"
  },
  {
    "text": "from doing its thing.  In fact, I can tell you that such   antiserum or such neutralizing antiserum can be achieved in a  ",
    "start": "1179000",
    "end": "1188000"
  },
  {
    "text": "number of ways.  One way to do it is just to take   the protein capsid,  the outer coat of the poliovirus  ",
    "start": "1188000",
    "end": "1197000"
  },
  {
    "text": "particle that I described before and inject that into an individual.    And that will on its own already evoke a measure of antiviral  ",
    "start": "1197000",
    "end": "1206000"
  },
  {
    "text": "immunity.  It will evoke a concentration of antiserum in the   blood of a patient.  Or, if you want to do it in a very  ",
    "start": "1206000",
    "end": "1215000"
  },
  {
    "text": "much more modern way,  you can sequence the proteins of the   poliovirus and determine the amino acid sequence.   ",
    "start": "1215000",
    "end": "1224000"
  },
  {
    "text": "And when you do that,  you can synthesize through organic   synthesis oligopeptides of 10 or 20 amino acids long.   ",
    "start": "1224000",
    "end": "1233000"
  },
  {
    "text": "And these oligopeptides reflect different parts of the poliovirus   coat protein.  So,  if here's the sequence of one of the  ",
    "start": "1233000",
    "end": "1239000"
  },
  {
    "text": "capsid proteins,  recall that capsid refers to the   coat that's shielding or protecting in this case poliovirus,   ",
    "start": "1239000",
    "end": "1246000"
  },
  {
    "text": "the single stranded viral RNA genome.  So, if here's one of the capsid   proteins, what you can do is to figure out the amino acid sequence  ",
    "start": "1246000",
    "end": "1253000"
  },
  {
    "text": "of this segment of the capsid protein, and then rather than   cutting it out from the capsid protein, you just synthesize it by  ",
    "start": "1253000",
    "end": "1260000"
  },
  {
    "text": "organic synthesis,  ten or twenty amino acid residues   long.  And when you inject that  ",
    "start": "1260000",
    "end": "1268000"
  },
  {
    "text": "oligopeptides into an individual,  that may also evoke some kind of   neutralizing antibody response.  In fact, as you might correctly  ",
    "start": "1268000",
    "end": "1276000"
  },
  {
    "text": "imagine, if we can look in more detail at the capsid structure,    I'm just going to draw it in a very primitive way here,   ",
    "start": "1276000",
    "end": "1285000"
  },
  {
    "text": "it's obviously much more complicated.  But if this is the capsid here,    it has an inside and an outside.  And the antibodies that you make  ",
    "start": "1285000",
    "end": "1294000"
  },
  {
    "text": "against an oligopeptide that is sticking out here on the outside   will be neutralizing,  i.e. the antiserum will be able to  ",
    "start": "1294000",
    "end": "1303000"
  },
  {
    "text": "recognize the outside of the virus particle and somehow inactivate it.    But if you were to use an oligopeptide antigen from over here,   ",
    "start": "1303000",
    "end": "1313000"
  },
  {
    "text": "which might be a part of the capsid protein that is deep inside,    well even though you might have a good reactivity with oligopeptide it  ",
    "start": "1313000",
    "end": "1322000"
  },
  {
    "text": "would not be neutralizing.  And that suggests the notion that   whatever is present in the antiserum is recognizing some external portion  ",
    "start": "1322000",
    "end": "1331000"
  },
  {
    "text": "of this protein which is sticking out.  And that external portion is   called an antigen.  So, there's a specific chemical  ",
    "start": "1331000",
    "end": "1341000"
  },
  {
    "start": "1340000",
    "end": "2369000"
  },
  {
    "text": "structure which is being recognized by the antiserum, and we   call that an antigen.  In principal, there are dozens of  ",
    "start": "1341000",
    "end": "1350000"
  },
  {
    "text": "distinct antigens on the surface of a poliovirus particle,    each of which one can, in principal,  make an immunizing antibody against.   ",
    "start": "1350000",
    "end": "1359000"
  },
  {
    "text": "Each of those can therefore be considered to be an antigen.    And, how can we imagine this antiserum as actually successfully  ",
    "start": "1359000",
    "end": "1368000"
  },
  {
    "text": "neutralizing the virus particle?  And here, this depended on actually   the biochemical characterization of antisera because one soon came to  ",
    "start": "1368000",
    "end": "1378000"
  },
  {
    "text": "learn that within antisera are what we call antibodies.    Or, keep in mind that in biology you never should ever use a simple  ",
    "start": "1378000",
    "end": "1387000"
  },
  {
    "text": "Anglo-Saxon word if you can use a much more complicated Greek or Latin   one.  So, we can always call these immunoglobulins.   ",
    "start": "1387000",
    "end": "1396000"
  },
  {
    "text": "You see the word right there.  Immunoglobulin represents an   antibody molecule,  and it turns out that much of the  ",
    "start": "1396000",
    "end": "1405000"
  },
  {
    "text": "protein in the soluble fraction of our serum consists of such   antibody molecules.  And these antibody molecules have a  ",
    "start": "1405000",
    "end": "1414000"
  },
  {
    "text": "very interesting structure which I'd like to dwell upon momentarily.    But before I do that, I'd just want to anticipate what I'm about to say  ",
    "start": "1414000",
    "end": "1422000"
  },
  {
    "text": "by indicating that we now realize that an antibody molecule can   recognize an antigen on the surface of the virus particle,   ",
    "start": "1422000",
    "end": "1430000"
  },
  {
    "text": "and the antibody molecule can actually physically bind to this   antigen.  So, we have an antigen antibody complex,   ",
    "start": "1430000",
    "end": "1438000"
  },
  {
    "text": "and that binding of the antibody molecule to the surface of the virus   particle is what results functionally in the neutralization  ",
    "start": "1438000",
    "end": "1446000"
  },
  {
    "text": "of its infectivity.  Or to put it another way,    given the fact that this particular capsid protein might be repeated,   ",
    "start": "1446000",
    "end": "1455000"
  },
  {
    "text": "let's say, 60 times around a spherical surface of a virus   particle, there might be,  in fact, 60 different antibody  ",
    "start": "1455000",
    "end": "1463000"
  },
  {
    "text": "molecules recognizing this repeated antigen which occurs on each of   these capsid proteins.  And therefore,   ",
    "start": "1463000",
    "end": "1471000"
  },
  {
    "text": "you can imagine in a very approximate way that if you have an   effective neutralizing antibody,  it's coating the surface of the  ",
    "start": "1471000",
    "end": "1479000"
  },
  {
    "text": "virus particle of antibody molecules,  and that clearly obstructs the   ability of the virus particle to initiate a subsequent round of  ",
    "start": "1479000",
    "end": "1486000"
  },
  {
    "text": "infection.  Here's what a single antibody molecule looks like,    and it has some critically important features.  First of all,   ",
    "start": "1486000",
    "end": "1493000"
  },
  {
    "text": "there is a specific region of the antibody that recognizes   the antigen.  In this case, I'm using as the  ",
    "start": "1493000",
    "end": "1501000"
  },
  {
    "text": "example the antigen an oligopeptide on the surface of the poliovirus   particle.  And that is located in this part of the antibody molecule.   ",
    "start": "1501000",
    "end": "1509000"
  },
  {
    "text": "Note, by the way, the antibody molecule is a heterotetramer.    It has two light chains, two small chains here on the right,   ",
    "start": "1509000",
    "end": "1518000"
  },
  {
    "text": "and two heavy chains.  Note that the cysteine disulphide bonds are   holding the entire assembly together.  So here, one is not relying on  ",
    "start": "1518000",
    "end": "1527000"
  },
  {
    "text": "hydrogen bonds to hold together this heterotetramer.    And note the following,  that there are portions of the  ",
    "start": "1527000",
    "end": "1536000"
  },
  {
    "text": "antibody molecule which may be specifically varied from one   antibody molecule to another over here, and other portions which are  ",
    "start": "1536000",
    "end": "1546000"
  },
  {
    "text": "standard operating hardware.  And let me elaborate on that for a   moment.  If you look in the serum of an individual and you try to analyze  ",
    "start": "1546000",
    "end": "1555000"
  },
  {
    "text": "the chemical structure of the antibody molecules in their serum,    you find that for a given type of antibody molecule like this,   ",
    "start": "1555000",
    "end": "1564000"
  },
  {
    "text": "all the antibody molecules share this constant here: light   purple domain.  They all have that in common.   ",
    "start": "1564000",
    "end": "1573000"
  },
  {
    "text": "They all have in common also the light blue domains.    But if you were able,  and we'll discuss this in a moment  ",
    "start": "1573000",
    "end": "1581000"
  },
  {
    "text": "how you could do so,  if you were able to analyze this   other portion,  you would find that when you look at  ",
    "start": "1581000",
    "end": "1589000"
  },
  {
    "text": "one antibody molecule,  it has a certain amino acid sequence   here, which is involved in antigen recognition, and that this amino  ",
    "start": "1589000",
    "end": "1597000"
  },
  {
    "text": "acid sequence on the light and heavy chain varies from one heterotetramer   to another heterotetramer.  And again, I'm going to reinforce  ",
    "start": "1597000",
    "end": "1605000"
  },
  {
    "text": "that.  But I want to indicate that there are, within the human   antiserum, millions of structurally distinct antibody molecules.   ",
    "start": "1605000",
    "end": "1615000"
  },
  {
    "text": "They share in common the structure down here up to this point.    And thereafter,  each of them has its own  ",
    "start": "1615000",
    "end": "1623000"
  },
  {
    "text": "idiosyncratic,  its own unusual,    its own particular private antigen recognition site,   ",
    "start": "1623000",
    "end": "1629000"
  },
  {
    "text": "which stems from a region or a pocket of the protein which is   involved in antigen recognition and has variable amino acid sequences.   ",
    "start": "1629000",
    "end": "1636000"
  },
  {
    "text": "Here, you see the way that an x-ray crystallographer would actually   visualize this molecule,  and you begin to realize that the  ",
    "start": "1636000",
    "end": "1643000"
  },
  {
    "text": "schematic that I showed you before,  in fact, is really doing a little   bit of violence to the real amino acid sequence,   ",
    "start": "1643000",
    "end": "1649000"
  },
  {
    "text": "to the real three dimensional structure, excuse me.    Now, note something else that is implicit in what I've just said but  ",
    "start": "1649000",
    "end": "1656000"
  },
  {
    "text": "I haven't said it explicitly,  there are actually two antigen   recognition sites,  one here and one here.   ",
    "start": "1656000",
    "end": "1664000"
  },
  {
    "text": "So, this antibody is in that sense bivalent.  And if there were,    for example, two poliovirus particles, one over here and one  ",
    "start": "1664000",
    "end": "1671000"
  },
  {
    "text": "over here, you could imagine in principal, although I'm not drawing   things to scale,  that this antibody molecule could  ",
    "start": "1671000",
    "end": "1679000"
  },
  {
    "text": "actually use one of its antigen recognition sites to bind over here   to one poliovirus particle,  and this to bind to another  ",
    "start": "1679000",
    "end": "1687000"
  },
  {
    "text": "poliovirus particle.  Now, I've told you that the antigen   is recognized by this antibody is an oligopeptide, which constitutes a  ",
    "start": "1687000",
    "end": "1695000"
  },
  {
    "text": "distinct chemical structure.  How many different oligopeptides of   ten amino acids long are there in the mathematical universe?   ",
    "start": "1695000",
    "end": "1705000"
  },
  {
    "text": "How many conceivable ones are there?     How many amino acids are there?  20?  So what's the number?  I heard  ",
    "start": "1705000",
    "end": "1714000"
  },
  {
    "text": "you all say 1020,  right?  So, that's an awful lot.    That's more than you can shake a stick at.  So that means that there  ",
    "start": "1714000",
    "end": "1722000"
  },
  {
    "text": "are, in principal,  essentially an infinite number of   oligopeptides of ten amino acids long, and each one of those could,   ",
    "start": "1722000",
    "end": "1730000"
  },
  {
    "text": "in principal constitute a distinct antigen that could be recognized by   the antibody molecule.  Note that what's happening here is  ",
    "start": "1730000",
    "end": "1738000"
  },
  {
    "text": "that a protein antigen such as one of these oligopeptides is being   recognized by another protein,  which is the antibody molecule.   ",
    "start": "1738000",
    "end": "1746000"
  },
  {
    "text": "And therefore,  we begin to imagine there's some   kind of lock and key complementarity where somehow the amino acid  ",
    "start": "1746000",
    "end": "1754000"
  },
  {
    "text": "sequence here recognizes and binds a complementary fashion to the antigen   that is being recognized,  and there's a physical association  ",
    "start": "1754000",
    "end": "1762000"
  },
  {
    "text": "which allows the antibody molecule then to attach tightly to the   antigen bearing poliovirus particle.   ",
    "start": "1762000",
    "end": "1770000"
  },
  {
    "text": "And, by the way,  to put it another way,    it could be that some of these poliovirus capsid proteins have not  ",
    "start": "1770000",
    "end": "1779000"
  },
  {
    "text": "yet been assembled in a virus particle.  And even if they aren't,    in principal a free protein, a capsid protein of poliovirus,   ",
    "start": "1779000",
    "end": "1788000"
  },
  {
    "text": "could also be recognized by an antibody molecule and be bound by   the antibody molecule.  Now, this creates several major  ",
    "start": "1788000",
    "end": "1797000"
  },
  {
    "text": "conceptual problems.  How on earth can the body make   antibody molecules that are able to recognize a poliovirus particle?   ",
    "start": "1797000",
    "end": "1806000"
  },
  {
    "text": "Well, you'll say that's easy.  Clearly, in our genes there must be   some kind of nucleotide sequence which has up here the ability encode  ",
    "start": "1806000",
    "end": "1814000"
  },
  {
    "text": "an antigen-binding site.  Note, by the way, the   antigen-binding site's actually composed of two different proteins.   ",
    "start": "1814000",
    "end": "1823000"
  },
  {
    "text": "Here's part of the antigen-binding site.  Here's another part of the   antigen-binding site.  So, it must be on two different  ",
    "start": "1823000",
    "end": "1831000"
  },
  {
    "text": "genes.  But, these two different genes create an antigen-binding site   which can recognize poliovirus.  Bind the poliovirus antigen and  ",
    "start": "1831000",
    "end": "1839000"
  },
  {
    "text": "neutralize it.  Well, that's well and good.    That's perfectly reasonable,  but let me tell you what's  ",
    "start": "1839000",
    "end": "1847000"
  },
  {
    "text": "unreasonable about that.  Each of us during his or her   lifetime are going to be infected by literally hundreds of viruses.   ",
    "start": "1847000",
    "end": "1855000"
  },
  {
    "text": "You get cold viruses almost every two, three, four, five   times a year.  By the time you get old,   ",
    "start": "1855000",
    "end": "1863000"
  },
  {
    "text": "you actually have acquired immunity to many of these,    but during the course of one's lifetime, the immune system has been  ",
    "start": "1863000",
    "end": "1871000"
  },
  {
    "text": "able to generate antiviral immunity and eliminate virtually all the   viral infections you ever got.  How many people do you know who  ",
    "start": "1871000",
    "end": "1879000"
  },
  {
    "text": "have actually died of a viral infection?  And yet each one of   these viruses is in principal able to replicate throughout your body  ",
    "start": "1879000",
    "end": "1887000"
  },
  {
    "text": "and kill you, and they never do?  So that means that the immune system   is extremely effective in developing an antibody or antibodies which  ",
    "start": "1887000",
    "end": "1896000"
  },
  {
    "text": "could neutralize infecting virus particles.  You might have the cold   for a day, a week,  or two weeks, but eventually the  ",
    "start": "1896000",
    "end": "1904000"
  },
  {
    "text": "immune system develops enough antibodies and other strategies to   eliminate the viral infections from your body.  I remember when my  ",
    "start": "1904000",
    "end": "1912000"
  },
  {
    "text": "grandfather was 94 years old and he got a cold.  And he hadn't had a   cold for 20 years because by the age of 75, he had been exposed to almost  ",
    "start": "1912000",
    "end": "1920000"
  },
  {
    "text": "every virus imaginable.  And so, when he got a cold at the   age of 94, his brain was still working, he'd forgotten how to blow  ",
    "start": "1920000",
    "end": "1928000"
  },
  {
    "text": "his nose.  It just hadn't happened to him.  He didn't know what it was   like to have a cold anymore.  So, it just goes to show you that  ",
    "start": "1928000",
    "end": "1936000"
  },
  {
    "text": "the immune system can be very versatile and very successful.    But this creates a major conceptual problem.  How do our genes know how  ",
    "start": "1936000",
    "end": "1944000"
  },
  {
    "text": "to create antigen-binding sites in our antibodies that recognize all of   the infectious viruses that are going to attack us during  ",
    "start": "1944000",
    "end": "1952000"
  },
  {
    "text": "a lifetime.  Do we have a gene for neutralizing   smallpox?  Do we have a gene for neutralizing poliovirus and  ",
    "start": "1952000",
    "end": "1960000"
  },
  {
    "text": "adenovirus, which gives us bad head colds.  And, rabies virus and   vesicular stomatitis virus,  and all other kinds of viruses that  ",
    "start": "1960000",
    "end": "1968000"
  },
  {
    "text": "we are going to experience in a lifetime.  Well,    possibly we do have a gene for each one of those.  But,   ",
    "start": "1968000",
    "end": "1976000"
  },
  {
    "text": "then I'm beginning to raise some other questions if you believe that,    which you shouldn't.  First of all, there are many  ",
    "start": "1976000",
    "end": "1984000"
  },
  {
    "text": "different distinct oligopeptide antigens on the surface of the   poliovirus particle.  If you look at the antibodies that  ",
    "start": "1984000",
    "end": "1992000"
  },
  {
    "text": "had been developed against a poliovirus capsid protein in an   immunized individual,  they have one antibody that  ",
    "start": "1992000",
    "end": "1999000"
  },
  {
    "text": "recognizes one part of these capsid protein, and another antibody that   recognized another part.  So, here's the surface of the  ",
    "start": "1999000",
    "end": "2007000"
  },
  {
    "text": "capsid protein blown up now,  and we can imagine there are   different oligopeptide epitopes on different parts of the protein.   ",
    "start": "2007000",
    "end": "2015000"
  },
  {
    "text": "And they're all ten amino acids long,  for example.  The fact is,    in individuals who have anti-poliovirus antibody,   ",
    "start": "2015000",
    "end": "2023000"
  },
  {
    "text": "you can find that there's an antibody that recognizes this   antigen, and one that recognizes this antigen, and another that  ",
    "start": "2023000",
    "end": "2032000"
  },
  {
    "text": "recognizes this antigen.  So, the number of distinct antigens   which the immune system has succeeded in making antibodies  ",
    "start": "2032000",
    "end": "2041000"
  },
  {
    "text": "against, vastly exceeds the number of infectious agents we're going to   experience in a lifetime.  And, that begins to undermine your  ",
    "start": "2041000",
    "end": "2050000"
  },
  {
    "text": "confidence in the notion that when we're born, we already possess the   genes to recognize different infectious agents,   ",
    "start": "2050000",
    "end": "2058000"
  },
  {
    "text": "and to construct neutralizing antibodies against them.    There's also another flaw in this whole notion that we inherit a set  ",
    "start": "2058000",
    "end": "2066000"
  },
  {
    "text": "of genes that enable us from the get-go to make specific   antibodies.  And that flaw comes from the  ",
    "start": "2066000",
    "end": "2074000"
  },
  {
    "text": "following notion.  Evolution cannot anticipate which   infectious agents each one of us is going to experience in a lifetime.   ",
    "start": "2074000",
    "end": "2082000"
  },
  {
    "text": "Let's say that some of us experience a totally new kind of a   viral infection which had never been experienced by our ancestors.   ",
    "start": "2082000",
    "end": "2091000"
  },
  {
    "text": "If the way of neutralizing that virus, and defending us against that   infection depended on using an antibody molecule whose sequence was  ",
    "start": "2091000",
    "end": "2100000"
  },
  {
    "text": "encoded in our germ line in the genes we inherited at birth,    then we might be in bad shape if that virus was a novel virus to  ",
    "start": "2100000",
    "end": "2108000"
  },
  {
    "text": "which the human race had never been exposed.    And in arguing that,  I'm telling you that it's impossible  ",
    "start": "2108000",
    "end": "2117000"
  },
  {
    "text": "to imagine a situation where our germ line, the set of genes we are   born with that we start life with,  already contains the information for  ",
    "start": "2117000",
    "end": "2126000"
  },
  {
    "text": "making each one of the different kinds of antibodies that   are in our antiserum.  How many different kinds of  ",
    "start": "2126000",
    "end": "2134000"
  },
  {
    "text": "antibodies are in our antiserum?  Well now, the whole notion becomes   even more stark because there's probably millions,   ",
    "start": "2134000",
    "end": "2142000"
  },
  {
    "text": "maybe even ten or 100 million distinct antibody molecules floating   around in our blood.  Each one in this case has the same  ",
    "start": "2142000",
    "end": "2150000"
  },
  {
    "text": "constant region down here.  You see the constant region,    and each one of these 100 million distinct antibody species has its  ",
    "start": "2150000",
    "end": "2158000"
  },
  {
    "text": "own antigen-combining site.  Now, if we want to pursue that   further, we have to begin to imagine how the immune system can make so  ",
    "start": "2158000",
    "end": "2165000"
  },
  {
    "text": "many different antibody molecules.  This itself is a major conceptual   challenge.  And now we have to go and know a little bit of cell  ",
    "start": "2165000",
    "end": "2173000"
  },
  {
    "text": "biology because if we look at the immune system,    and there are cells forming in the immune system,   ",
    "start": "2173000",
    "end": "2180000"
  },
  {
    "text": "we find a set of cells that are called B cells or a subset of B   cells that are called plasma cells.  And the plasma cells, and there's a  ",
    "start": "2180000",
    "end": "2188000"
  },
  {
    "text": "whole bunch of different plasma cells.    So the plasma cells are floating around in the circulation,   ",
    "start": "2188000",
    "end": "2195000"
  },
  {
    "text": "and the plasma cells are able to secrete antibody molecules into the   serum.  And they are abundant.  They're around by the billions  ",
    "start": "2195000",
    "end": "2203000"
  },
  {
    "text": "inside our body.  And these plasma cells are   constantly secreting antibody molecules into the serum around them  ",
    "start": "2203000",
    "end": "2211000"
  },
  {
    "text": "into the plasma around them.  And these are the antibody   molecules I've been talking about here, the antibody molecules that  ",
    "start": "2211000",
    "end": "2219000"
  },
  {
    "text": "are capable of neutralizing poliovirus particles.    So, this now creates another conceptual question.   ",
    "start": "2219000",
    "end": "2226000"
  },
  {
    "text": "Let's imagine for the sake of argument that in our blood stream   there are 100 million distinct antigen species floating around.   ",
    "start": "2226000",
    "end": "2233000"
  },
  {
    "text": "And I don't mean 100 million molecules.  I mean there's a million   molecules, and each one of these species has a different  ",
    "start": "2233000",
    "end": "2241000"
  },
  {
    "text": "antigen-binding site.  So, there may be many   antigen-binding sites.  There may be many antibody  ",
    "start": "2241000",
    "end": "2248000"
  },
  {
    "text": "molecules.  There may be million of this kind of   antibody that recognize this antigen.  There may be millions of this  ",
    "start": "2248000",
    "end": "2256000"
  },
  {
    "text": "antibody recognizing this antigen,  millions of this antibody   recognizing this antigen on the surface of poliovirus.   ",
    "start": "2256000",
    "end": "2264000"
  },
  {
    "text": "And I'm saying there could be a million distinct species of   antibodies, each species being defined by the antigen that  ",
    "start": "2264000",
    "end": "2272000"
  },
  {
    "text": "recognizes and by the structure of its antigen-recognizing site,    its antigen-binding site.  In other words,   ",
    "start": "2272000",
    "end": "2280000"
  },
  {
    "text": "to repeat myself,  what distinguishes one species of   antibodies from another is the amino acid sequence,   ",
    "start": "2280000",
    "end": "2286000"
  },
  {
    "text": "the structure of this particular region of the antibody molecule that   makes one species of antibody different from the other.   ",
    "start": "2286000",
    "end": "2292000"
  },
  {
    "text": "And with all that in mind,  we have two alternative scenarios.    Let's again say there's a million different species of antibodies  ",
    "start": "2292000",
    "end": "2299000"
  },
  {
    "text": "being secreted into the antiserum at any one point in time.    This cell could make all million.  This cell could make the whole  ",
    "start": "2299000",
    "end": "2305000"
  },
  {
    "text": "million species.  This cell could,    and this cell could.  In other words,   ",
    "start": "2305000",
    "end": "2312000"
  },
  {
    "text": "each one of these B cells could be multitalented,   ",
    "start": "2312000",
    "end": "2318000"
  },
  {
    "text": "able to simultaneously make a million different kinds of antibody   molecules.  The opposite model is as follows, and that is that this B  ",
    "start": "2318000",
    "end": "2329000"
  },
  {
    "text": "cell makes one species of antibody.  We'll call it antibody A, and this   species makes another species of antibody molecule.   ",
    "start": "2329000",
    "end": "2340000"
  },
  {
    "text": "So, this B cell makes antibody A.  This B cell makes antibody B.  This   B cell makes antibody C.  And keep in mind that when I'm  ",
    "start": "2340000",
    "end": "2348000"
  },
  {
    "text": "saying antibody A,  B, and C, I mean A has a certain   antigen-binding site.  Be has another antigen binding site.   ",
    "start": "2348000",
    "end": "2357000"
  },
  {
    "text": "C has yet another antigen binding site.  And, we can distinguish   between these two alternative mechanistic models by looking at the  ",
    "start": "2357000",
    "end": "2365000"
  },
  {
    "text": "disease called multiple myeloma.  And what you have in multiple   myeloma is the following.  All of a sudden,   ",
    "start": "2365000",
    "end": "2373000"
  },
  {
    "start": "2369000",
    "end": "2596000"
  },
  {
    "text": "the blood stream becomes full of much greatly elevated levels of   antibody molecules.  They're present in the blood stream.   ",
    "start": "2373000",
    "end": "2381000"
  },
  {
    "text": "Now, normally,  if you look at all the antibody   molecules in the blood stream and you were to separate them by some  ",
    "start": "2381000",
    "end": "2388000"
  },
  {
    "text": "kind of electrophoretic technique which distinguished them on the   basis of subtle differences in the amino acid sequence,   ",
    "start": "2388000",
    "end": "2396000"
  },
  {
    "text": "and let's not worry about exactly how you do that.    But we've talked about a million different antibody species.   ",
    "start": "2396000",
    "end": "2403000"
  },
  {
    "text": "They're chemically slightly different from one another by virtue   of the antigen-recognizing site.  And if you could separate them by  ",
    "start": "2403000",
    "end": "2411000"
  },
  {
    "text": "some kind of system that separated them on the basis of their charge,    you'd find a whole spectrum of different antibody molecules,   ",
    "start": "2411000",
    "end": "2418000"
  },
  {
    "text": "a million in this large,  heterogeneous mixture of antibody   molecules, each species found somewhere or another in this very  ",
    "start": "2418000",
    "end": "2426000"
  },
  {
    "text": "broad distribution of 100 million distinct species which are all mixed   together in the antiserum.  If you look at the serum or the  ",
    "start": "2426000",
    "end": "2433000"
  },
  {
    "text": "plasma of a patient suffering from multiple myeloma,    what you find is the following,  that one species of antibody  ",
    "start": "2433000",
    "end": "2441000"
  },
  {
    "text": "molecules dominates over all the other ones.  And so now,    whereas that single species might only be on average one millionth of  ",
    "start": "2441000",
    "end": "2449000"
  },
  {
    "text": "the total antibody complement in the blood.  In those suffering from   myeloma, or sometimes it's called multiple myeloma,   ",
    "start": "2449000",
    "end": "2457000"
  },
  {
    "text": "now one single antibody species may represent 60, 70,    or 80% of all the antibody molecules in the blood.   ",
    "start": "2457000",
    "end": "2465000"
  },
  {
    "text": "And clearly something has gone very wrong.  And if you look at what   happened in the case of an individual of multiple myeloma,   ",
    "start": "2465000",
    "end": "2474000"
  },
  {
    "text": "if we look at that diagram up there,  what you see now is that instead of   there being many different B cells that are equivalently represented in  ",
    "start": "2474000",
    "end": "2483000"
  },
  {
    "text": "the blood stream,  now one of the B cell types has   begun to multiple uncontrollably,  and this vasicular B cell type,   ",
    "start": "2483000",
    "end": "2492000"
  },
  {
    "text": "which I indicate up there,  which happens to be specifically   able to make antibody C in this model, now this particular species  ",
    "start": "2492000",
    "end": "2502000"
  },
  {
    "text": "of B cells is now a predominant constituent of the population of B   cells in the blood.  So just to reiterate,   ",
    "start": "2502000",
    "end": "2510000"
  },
  {
    "text": "in the normal blood, there are a million different sub-populations of   B cells.  But in these individuals,  one of the sub-populations of B  ",
    "start": "2510000",
    "end": "2518000"
  },
  {
    "text": "cells has expanded.  It's created a monoclonal growth.    Keep in mind monoclonal refers to the fact that all the cells in this  ",
    "start": "2518000",
    "end": "2525000"
  },
  {
    "text": "tumor, and there is a tumor,  descend from the same ancestor.    So, it's a monoclonal growth.  It's a kind of cancer.   ",
    "start": "2525000",
    "end": "2533000"
  },
  {
    "text": "It's a kind of blood cancer.  And all the cells in this   population make the identical antibody molecule,   ",
    "start": "2533000",
    "end": "2541000"
  },
  {
    "text": "which explains this very homogeneous peak here riding above the very   heterogeneous mixture of antibodies,  the background heterogeneity that  ",
    "start": "2541000",
    "end": "2549000"
  },
  {
    "text": "normally characterizes normal serum.    And what that clearly indicates is that each different B cell or plasma  ",
    "start": "2549000",
    "end": "2556000"
  },
  {
    "text": "cell as you will like to call it in our normal serum is specialized to   make its own particular kind of antibody.  It's not that a single B  ",
    "start": "2556000",
    "end": "2564000"
  },
  {
    "text": "cell can make a million different antibodies.  Each B cell makes a   very specific kind of antibody.  And when I say a specific antibody  ",
    "start": "2564000",
    "end": "2572000"
  },
  {
    "text": "or a specific antibody species,  again I'm referring to an antibody   that has a specific antigen-binding site.   ",
    "start": "2572000",
    "end": "2580000"
  },
  {
    "text": "Or to put it another way,  all of the antibody molecules coming   out of a single B cell are identical with one another.   ",
    "start": "2580000",
    "end": "2589000"
  },
  {
    "text": "That, then, raises the question of how the B cell learns how to make   that antibody molecule and not other antibody molecules.   ",
    "start": "2589000",
    "end": "2599000"
  },
  {
    "text": "There's yet another puzzle we have to answer, and that's the following.    If you look at the serum response of an individual to a viral  ",
    "start": "2599000",
    "end": "2608000"
  },
  {
    "text": "infection, it looks like this.  And here, let's look at what's   present in the ordinate,  and it's on a log scale as you can  ",
    "start": "2608000",
    "end": "2616000"
  },
  {
    "text": "see here, and what's present on the abscissa.  If one is initially   exposed to an antigen and develops an immunity, then here is the wave  ",
    "start": "2616000",
    "end": "2624000"
  },
  {
    "text": "of antibody production and the concentration of antibody against,    let's say, poliovirus that is present in the blood of a recently  ",
    "start": "2624000",
    "end": "2632000"
  },
  {
    "text": "infected individual.  They're exposed to the antigen,    or in this case the poliovirus capsid protein.   ",
    "start": "2632000",
    "end": "2640000"
  },
  {
    "text": "In the days and weeks that follow,  they develop a significant level of   antibody which is used to neutralize,  in this case the infected poliovirus  ",
    "start": "2640000",
    "end": "2649000"
  },
  {
    "text": "particles.  And then once the poliovirus is cleared from the   system, i.e. once all the infectious particles have been neutralized,   ",
    "start": "2649000",
    "end": "2658000"
  },
  {
    "text": "then the antibody molecules go down almost to zero,    and there's virtually no antibody against poliovirus left around.   ",
    "start": "2658000",
    "end": "2668000"
  },
  {
    "text": "But look what happens when that individual is re-exposed to   poliovirus years later.  All of a sudden, now he or she  ",
    "start": "2668000",
    "end": "2677000"
  },
  {
    "text": "mounts a massive antibody response vastly higher than the initial one.    Well, you say it's only twofold higher than this.   ",
    "start": "2677000",
    "end": "2686000"
  },
  {
    "text": "But let's look at the ordinate.  This is a logarithmic plot.  So,    on this plot, the secondary antibody response is maybe 100 or 200 times  ",
    "start": "2686000",
    "end": "2695000"
  },
  {
    "text": "more vigorous, much higher antibody production.    Let's think about this time years later when that person is exposed to  ",
    "start": "2695000",
    "end": "2704000"
  },
  {
    "text": "a second virus.  Let's say that person is exposed   subsequently to cold virus,  adenovirus.  Does the exposure to  ",
    "start": "2704000",
    "end": "2713000"
  },
  {
    "text": "poliovirus here in the blue curve help that person develop an   adenovirus antibody response?  The answer is absolutely not.   ",
    "start": "2713000",
    "end": "2721000"
  },
  {
    "text": "There's no cross-immunity.  And so,  when that individual years later   becomes exposed to adenovirus,  there's once again the same kind of  ",
    "start": "2721000",
    "end": "2730000"
  },
  {
    "text": "initial response that happened as a consequence of previously being   exposed to poliovirus.  It's a rather weak response.   ",
    "start": "2730000",
    "end": "2739000"
  },
  {
    "text": "It's effective enough in developing the initial virus eliminating   ability, but it's not very strong.  What is this telling us?  I'm glad  ",
    "start": "2739000",
    "end": "2747000"
  },
  {
    "text": "I asked that question.  It's telling us that that immune   system is able to remember over a period of months,   ",
    "start": "2747000",
    "end": "2755000"
  },
  {
    "text": "years, and decades that a previous exposure to this antigen has   occurred because here the immune system in this second red curve  ",
    "start": "2755000",
    "end": "2763000"
  },
  {
    "text": "knows, somehow remembers,  that there was an exposure years   earlier.  And not only does it remember and  ",
    "start": "2763000",
    "end": "2772000"
  },
  {
    "text": "respond rapidly,  but it responds much more vigorously.    And here now,  we begin to recognize some of the  ",
    "start": "2772000",
    "end": "2780000"
  },
  {
    "text": "outlines of immunity because the immune system remembers this earlier   exposure, and when it's provoked a second time, through an accidental  ",
    "start": "2780000",
    "end": "2788000"
  },
  {
    "text": "and inadvertent exposure to poliovirus on a second occasion,    now it really goes to town.  And now it creates antisera which is  ",
    "start": "2788000",
    "end": "2796000"
  },
  {
    "text": "much more vigorous than it was during the first exposure.    If the first exposure had never occurred, there wouldn't be such a  ",
    "start": "2796000",
    "end": "2804000"
  },
  {
    "text": "vigorous response.  Look at this one over here.    So now, we begin to realize two mysteries that we have to explain  ",
    "start": "2804000",
    "end": "2811000"
  },
  {
    "text": "next time in our further discussion of the immune system.    First of all, how do B cells figure out how to make so many different  ",
    "start": "2811000",
    "end": "2819000"
  },
  {
    "text": "kinds of antibody molecules.  And secondly, how does the immune   system remember from one decade to the next, that exposure to a  ",
    "start": "2819000",
    "end": "2827000"
  },
  {
    "text": "previous antigen has occurred which merits a vigorous response.    See you then on Friday.  ",
    "start": "2827000",
    "end": "2833666"
  }
]